ONWRF (Onward Medical NV) Tariff Resilience Score: 6/10 (As of Jul. 05, 2026)


ONWRF Onward Medical NV ONWRF
37 GF Score
Price $2.94
GF Value $155.17
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Onward Medical NV Tariff Resilience Score?

Onward Medical NV ONWRF 37 Tariff Resilience Score is 6 as of Jul. 05, 2026. GuruFocus rates ONWRF with a GF Score™ of 37/100 and a GF Value™ of $155.17 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,369 Biotechnology companies, Onward Medical NV ranks better than 75.97% on this metric.

Onward Medical NV has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.

Onward Medical NV has Onward Medical's medical device focus faces moderate tariff risks. While some components are sourced internationally, the company benefits from healthcare industry exemptions. Historical tariffs have had limited impact, and alternative suppliers offer mitigation options.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Onward Medical NV might have Average Resilient.

Onward Medical NV  (OTCPK:ONWRF) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Onward Medical NV Tariff Resilience Score Related Terms

ONWRF vs VRTX, REGN, ALNY: Tariff Resilience Score Comparison

For the Biotechnology subindustry, Onward Medical NV's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Onward Medical NV Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Onward Medical NV's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Onward Medical NV's Tariff Resilience Score falls into.


ONWRF
37GF Score
Onward Medical NV ONWRF
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 6 mean?
Onward Medical NV (ONWRF) has a Tariff Resilience Score of 6 as of Jul. 05, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Onward Medical NV ranks #329 out of 1369 companies in the Biotechnology industry, placing it in the top 24%.
Is Onward Medical NV's Tariff Resilience Score too high?
Onward Medical NV's current Tariff Resilience Score is 6. The Biotechnology industry median Tariff Resilience Score is 4.00. Onward Medical NV's value of 6 is 50% above this industry median. Based on the distribution chart, Onward Medical NV ranks #329 out of 1369 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Onward Medical NV has a GF Score™ of 37/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Onward Medical NV's Tariff Resilience Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Onward Medical NV ranks #329 out of 1369 companies for Tariff Resilience Score. This places Onward Medical NV in the top 24% of its industry — outperforming the majority of peers. The industry median Tariff Resilience Score is 4.00. Onward Medical NV's value of 6 is 50% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,369 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Onward Medical NV's current Tariff Resilience Score of 6 is 50% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Onward Medical NV's current Tariff Resilience Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Onward Medical NV stock overvalued right now?
Based on GuruFocus' analysis, Onward Medical NV (ONWRF) is currently considered Possible Value Trap. The stock's GF Value™ is $155.17, compared to a current price of $2.94 — trading 98.1% below its estimated fair value. The current Tariff Resilience Score is 6 and 50% above the Biotechnology industry median of 4.00. Onward Medical NV's overall GF Score™ is 37/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Onward Medical NV (ONWRF), the current Tariff Resilience Score is 6 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Onward Medical NV (ONWRF) Overvalued in 2026?

Based on GuruFocus' analysis, Onward Medical NV stock appears to be undervalued. The current stock price of $2.94 is trading 98.1% below its estimated GF Value™ of $155.17. GuruFocus considers Onward Medical NV to be Possible Value Trap.

Key valuation signals for ONWRF:

  • Tariff Resilience Score: 6
  • GF Value™: $155.17 vs. price of $2.94 (98.1% below fair value)
  • GF Score™: 37/100 with 4 warning signs
  • Industry Position: 50% above the Biotechnology median (#329 of 1369)

No single metric tells the full story. See the ONWRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Onward Medical NV Business Description

Other Exchanges 63E:GermanyONWD:Belgium
Address Schimmelt 2, Eindhoven, NH, NLD, NL-5656
Onward Medical NV is developing and commercializing therapies to enable functional recovery for people with Spinal Cord Injury (SCI). The company's technology platforms are based on ONWARD ARC Therapy (ARC Therapy), targeted, programmed electrical stimulation of the spinal cord designed to restore movement, independence, and health in people with SCI.
37GF Score

Get the complete analysis for ONWRF

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.94
Price
$155.17
GF Value